Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition(s):Neuromuscular DiseasesLast Updated:March 27, 2019Unknown status
Hide Studies Not Open or Pending
Condition(s):Neuromuscular DiseasesLast Updated:March 27, 2019Unknown status
Condition(s):Covid19; Systemic Autoimmune Disease; Inflammatory Rheumatism; Auto Inflammatory DiseasesLast Updated:January 13, 2023Terminated
Condition(s):COVID-19Last Updated:November 15, 2021Recruiting
Condition(s):Lynch SyndromeLast Updated:March 9, 2021Completed
Condition(s):Amyotrophic Lateral SclerosisLast Updated:January 26, 2023Recruiting
Condition(s):Cardiac Surgery, Heart Surgery, Discharge Education, Nursing, Telenursing, m-Health, Quality of Life, RecoveryLast Updated:November 30, 2022Recruiting
Condition(s):Osteoarthritis, KneeLast Updated:May 23, 2022Completed
Condition(s):Electromagnetic FieldsLast Updated:March 14, 2023Completed
Condition(s):Endometriosis; Endometrial DiseasesLast Updated:August 8, 2022Recruiting
Condition(s):Cortisol OverproductionLast Updated:July 30, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.